Research

Genetic testing pinpoints cardiovascular risk in patients with aortic disorders
February 10, 2024
A new Mayo Clinic systematic review has shed light on genetically inherited aortic disorders in patients, highlighting the importance of early diagnosis and treatment for those with inherited cardiovascular risk.Powered by ...
Read More
Growing mini-organs to find new treatments for complex disease
February 4, 2024
Microscopic view of an intestinal organoid Mayo Clinic investigators are growing three-dimensional human intestines in a dish to track disease and find new cures for complex conditions such as inflammatory bowel disease. These mini organs function like human intestines with the ability to proce...
Read More
New Mayo Clinic stem cell research to take flight into space
January 27, 2024
A Mayo Clinic research experiment will be part of a payload that launches into space from NASA's Kennedy Space Center in Cape Canaveral, Florida, on Jan. 29, subject to weather conditions and other factors. The research team from the lab of Dr. Abba Zubair is preparing stem cells for the flight...
Read More
Research fuels advances in bile duct cancer care
January 27, 2024
Bile duct cancer, also known as cholangiocarcinoma, forms in the thin tubes that carry bile from your liver to your gallbladder and small intestine. Though relatively rare, cholangiocarcinoma is often diagnosed in later stages, making it more difficult to treat, and cases in the U.S. are increa...
Read More
Mayo Clinic engages Cerebras to deliver potent computing power, scale AI transformation  
January 27, 2024
ROCHESTER, Minn. — Mayo Clinic, the world’s No. 1 hospital and a global leader in advancing trusted generative artificial intelligence (AI) healthcare applications, has announced a multi-year strategic collaboration with Cerebras Systems to develop multimodal large language models (LLMs) to...
Read More
Highlights of Mayo Clinic research advancements in 2023
January 27, 2024
Mayo Clinic researchers make new discoveries, develop first-of-its-kind tools and technologies and constantly improve upon existing ones with the goal to provide the best in healthcare. The following 10 stories are a round-up of some of the most significant medical research advances at Mayo Cli...
Read More
Mayo Clinic Platform and Techcyte announce a strategic collaboration to transform the global practice of pathology
January 27, 2024
ROCHESTER, Minn. and OREM, Utah — Mayo Clinic Platform, a collaborative ecosystem for healthcare innovation, and Techcyte, a world leader in AI-based digital pathology, are working together to transform the global practice of pathology through the creation of a digital pathology platform.  ...
Read More
10 significant studies from Mayo Clinic’s Center for Individualized Medicine in 2023
January 27, 2024
In 2023, researchers and physicians at Mayo Clinic's Center for Individualized Medicine blazed a trail of genomic and multi-omic research and scientific discoveries. The center's innovative investigations hold a transformative potential to predict, prevent, treat and cure diseases using indiv...
Read More
A year of advancing novel regenerative biotherapeutics toward patient care
January 27, 2024
Mayo Clinic's Center for Regenerative Biotherapeutics has advanced the development and biomanufacturing of novel therapeutics, called biologics, for cancer and inflammatory conditions into clinical trials. "My dream has been to develop innovative technologies that go beyond treating symptoms ...
Read More
Mayo Clinic Comprehensive Cancer Center highlights research advances in 2023
January 27, 2024
ROCHESTER, Minn. — Mayo Clinic researchers make new discoveries, develop first-of-its-kind tools and technologies and constantly improve upon existing ones with the goal to provide the best in healthcare. The following five stories are a round-up of some of the most significant medical resear...
Read More
Electric barrier-induced voluntary abstinence reduces alcohol seeking in male, but not female, iP rats.
Maintaining abstinence and preventing relapse are key to the successful recovery from alcohol use disorder. There are two main ways individuals with alcohol use disorder abstain from alcohol use: forced (e.g., incarceration) and voluntary. Voluntary abstinence is often evoked due to the negative consequences associated with excessive alcohol consumption. This study investigated relapse-like behavior to alcohol seeking following acute, forced, and voluntary abstinence. Male rats had increased operant self-administration responding throughout training compared to females; however, females consumed greater amounts of alcohol in g/kg. Both male and female rats achieved voluntary abstinence, whic...
Read Article
Can the resting state peak alpha frequency explain the relationship between temporal resolution power and psychometric intelligence?
The temporal resolution power (TRP) hypothesis states that individuals with higher TRP, as reflected by a higher performance on several psychophysical timing tasks, perform better on intelligence tests due to their ability to process information faster and coordinate their mental operations more effectively. It is proposed that these differences in TRP are related to the rate of a master clock based on neural oscillations. The present study aimed to investigate whether the peak alpha frequency (PAF) measured via electroencephalography (EEG) reflects a psychophysiological measure of this rate and its potential role in explaining the relationship between TRP and psychometric intelligence. A sa...
Read Article
Kamin blocking is disrupted by low-dose ketamine in mice: Further implications for aberrant stimulus processing in schizophrenia.
Previous studies have shown that low doses of ketamine, an N-methyl-D-aspartate receptor antagonist, produce aberrantly strong internal representations of associatively activated but absent stimuli in humans and nonhuman animals, suggesting the validity of ketamine treatment as a preclinical model of the positive symptoms of schizophrenia, including hallucinations and delusions. However, whether acute ketamine treatment also impairs the ability to ignore present but informationally redundant stimuli, which is another hallmark of schizophrenia, remains unclear. Accordingly, the present study investigated whether injections of low-dose ketamine attenuate Kamin blocking in an appetitive conditi...
Read Article
Predictions about reward outcomes in rhesus monkeys.
Human infants and nonhuman animals respond to surprising events by looking longer at unexpected than expected situations. These looking responses provide core cognitive evidence that nonverbal minds make predictions about possible outcomes and detect when these predictions fail to match reality. We propose that this phenomenon has crucial parallels with the processes of reward prediction error, indexing the difference between expected and actual reward outcomes. Most work on reward prediction errors to date involves neurobiological techniques that cannot be implemented in many relevant populations, so we developed a novel behavioral task to assess monkeys’ predictions about reward outcomes...
Read Article
Morphine exposure during adolescence induces enduring social changes dependent on adolescent stage of exposure, sex, and social test.
Drug exposure during adolescence, when the “reward” circuitry of the brain is developing, can permanently impact reward-related behavior into adulthood. Epidemiological studies show that opioid treatment during adolescence, such as pain management for a dental procedure or surgery, increases the incidence of psychiatric illness including substance use disorders. Moreover, the opioid epidemic currently in the United States is affecting younger individuals raising the impetus to understand the pathogenesis of the negative effects of opioids. One reward-related behavior that develops during adolescence is social behavior. We previously demonstrated that developmental changes in the nucleus ...
Read Article